1-3 of 3
Nicole M Haynes
Close
Sort by
Journal Articles

CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

Simon J. Harrison, Tamia Nguyen, Marzia Rahman, Jeremy Er, Jessica Li, Katherine Li, Nikoletta Lendvai, Jordan M. Schecter, Arnob Banerjee, Tito Roccia, Brad Foulk, Junchen Gu, Hao Zhao, Denis Smirnov, Ana Slaughter, Carolina Lonardi, Erin Lee, Loreta Marquez, Shirin Jadidi, Octavio Costa Filho, Nitin Patel, Dong Geng, Nicole M Haynes, Hannah Kelly, Stephen Lade, Sean Grimmond, Piers Blombery
Journal: Blood
Blood (2023) 142 (Supplement 1): 6939.
https://doi.org/10.1182/blood-2023-178806
Published: 2023
Journal Articles

Adoptive transfer of gene-engineered CD4 + helper T cells induces potent primary and secondary tumor rejection

Maria Moeller, Nicole M. Haynes, Michael H. Kershaw, Jacob T. Jackson, Michele W. L. Teng, Shayna E. Street, Loretta Cerutti, Stephen M. Jane, Joseph A. Trapani, Mark J. Smyth, Phillip K. Darcy
Journal: Blood
Blood (2005) 106 (9): 2995–3003.
https://doi.org/10.1182/blood-2004-12-4906
Published: 2005
Journal Articles

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

Nicole M. Haynes, Joseph A. Trapani, Michèle W. L. Teng, Jacob T. Jackson, Loretta Cerruti, Stephen M. Jane, Michael H. Kershaw, Mark J. Smyth, Phillip K. Darcy
Journal: Blood
Blood (2002) 100 (9): 3155–3163.
https://doi.org/10.1182/blood-2002-04-1041
Published: 2002